Guido Magni, Director at Aprea Therapeutics, Inc. (APRE), bought 6,500 shares at $15.00 ($98K) on 2019-10-07, disclosed to the SEC on 2019-10-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.